Medications - Page 13

July 16

The key to living longer could be tied to a surprising substance, study suggests

Psilocybin treatment, or magic mushrooms, showed cellular life extension in aged mice, according to Emory University researchers. The study co-author discusses the results.

July 15

New weekly injection for Parkinson's could replace daily pill for millions, study suggests

Research shows promising results for a weekly injectable Parkinson's treatment that maintains consistent medication levels, possibly eliminating multiple daily pills.

July 15

Scientists crack the code on new vaccine for deadly plague bacteria

New bacterial mRNA vaccine technology shows promise in fighting plague, and could help address the global threat of antibiotic resistance through rapid vaccine development.

July 2

Popular weight-loss drugs show promising new power against debilitating migraines

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life improvements occurring despite minimal weight changes.

July 2

Breast cancer survivors may have lower risk of developing Alzheimer's disease, study finds

Breast cancer treatment might offer protection against Alzheimer's disease, with a study of 70,000 survivors showing lower dementia risk, especially with radiation therapy.

June 28

New drug helps patients lose nearly 25% of body weight in early trials

Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly one-quarter of their body weight in early trials.

June 27

CDC committee moves to phase out controversial mercury ingredient from flu vaccines

CDC advisory committee recommends thimerosal-free influenza vaccines for all adults and children, despite claims that the mercury-based preservative poses no health risks.

June 24

Single dose of 'magic mushrooms' provides 5 years of depression relief, researchers find

The magic mushroom compound psilocybin shows long-lasting antidepressant effects in a clinical trial, with patients reporting less anxiety and improved daily functioning years later.

June 23

Diabetic patients taking GLP-1s may face increased risk of eye disease, study suggests

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure increasing danger of macular degeneration.

June 19

FDA approves first twice-yearly injection that prevents HIV infection

The injectable HIV prevention treatment Yetzugo, made by Gilead Sciences, has received FDA approval, offering a twice-yearly alternative to daily medications.